Philadelphia, Pa., Feb. 27, 2018 -- The Adult Congenital Heart Association (ACHA) applauds the House of Representatives for passage of the Congenital Heart Futures Reauthorization Act (CHFRA), H.R. 1222.
|
|||
Congenital heart defects are the most prevalent category of birth defects, affecting nearly 1 in 100 babies; more than five percent will not live to see their first birthday, and those who receive successful intervention are not cured. Children and adults with congenital heart disease (CHD) require ongoing, costly, specialized cardiac care, and face a lifelong risk of permanent disability and premature death.
This legislation will ensure that critical CHD activities at the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) will continue. First authorized in 2010, these efforts have improved our understanding of CHD across the lifespan, the age-specific prevalence of CHD, and factors impacting when people with CHD do not receive appropriate specialty care. House passage of CHFRA is the first step to allowing the CDC and NIH to build upon their existing programs to address an important public health issue and improve the quality of life and care for individuals with CHD.
“We applaud the House of Representatives on passage of the Congenital Heart Futures Reauthorization Act, which will improve the lives of all people with CHDs in our country. The entire CHD community also extends a special thanks to Representatives Gus Bilirakis and Adam Schiff for their leadership in introducing CHFRA and their tireless work for it to be considered in the House,” said Mark Roeder, President and CEO of ACHA. “Now, we will turn our attention to the Senate, in hopes that it, too, will act and CHFRA will become law this year.”
More than 180 Adult Congenital Heart Association advocates from 32 different states will be on Capitol Hill in Washington, D.C. this week, thanking House of Representatives members who have continued to support individuals with congenital heart disease (CHD) and ensuring U.S. Senators are informed and educated on this critical bi-partisan issue.
###
About the Adult Congenital Heart Association
The Adult Congenital Heart Association (ACHA) is a national not-for-profit organization dedicated to improving the quality of life and extending the lives of adults with congenital heart disease (CHD). ACHA serves and supports the more than one million adults with CHD, their families and the medical community—working with them to address the unmet needs of the long-term survivors of congenital heart defects through education, outreach, advocacy, and promotion of ACHD research. For more information about ACHA, contact (888) 921-ACHA or visit www.achaheart.org.
Attachment:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/b41a6b8e-25fb-48eb-a477-0055113cf894
Chris Murray Adult Congenital Heart Association (610) 254-7422 [email protected]


Audi, SAIC Launch China Innovation Hub for New AUDI Models
ByteDance Secures $29.6 Billion Loan to Boost AI Investment
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses
Qantas Near-Miss Raises Sydney Air Traffic Controller Fatigue Concerns
Shein Shares Drop 5% After Weak Hong Kong IPO Debut
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up
Adobe Names Anil Chakravarthy CEO as AI Push Accelerates
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada
South Korea, US Discuss Chip Investments Amid Tariff Plans
Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab
OpenAI Launches GPT-6 Astra With Advanced AI Agent Capabilities 



